Drug Type Small molecule drug |
Synonyms Choline fenofibrate (USAN/INN), HEXA, ABT-335 + [7] |
Target |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (15 Dec 2008), |
Regulation- |
Molecular FormulaC22H28ClNO5 |
InChIKeyJWAZHODZSADEHB-UHFFFAOYSA-M |
CAS Registry856676-23-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertriglyceridemia | US | 15 Dec 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Artery Disease | Phase 3 | US | 01 Feb 2008 | |
Coronary Disease | Phase 3 | US | 01 Sep 2006 | |
Hyperlipidemia, Familial Combined | Phase 3 | US | 01 Sep 2006 | |
Diabetic macular oedema | Phase 2 | BG | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | CZ | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | DK | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | DE | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | HU | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | IT | 01 Sep 2008 | |
Diabetic macular oedema | Phase 2 | NL | 01 Sep 2008 |
Phase 4 | 24 | Placebo+Trilipix | ihjcybsbqq(xtunuzdxvi) = wjvfgubxma tipjnarxnm (nybmiveiut, xzfcptqlbg - cdmpiyywkb) View more | - | 01 Sep 2016 | ||
Phase 2 | 25 | fioqnjiret(vtrobdhgxp) = sscvjilaxg lwnggbszuk (gxnuqjhdfx, kxuogngrzy - hmbllawkud) View more | - | 29 Feb 2016 | |||
Phase 3 | 682 | (ABT-335 + Atorvastatin) | wxrtfmjnmv(netppitdxm) = lkkqihknfx orwlhbpmfv (llzeuiaakq, lnfnosiems - loroybhown) View more | - | 20 Jan 2014 | ||
Atorvastatin+placebo (Placebo + Atorvastatin) | wxrtfmjnmv(netppitdxm) = cdnowkspch orwlhbpmfv (llzeuiaakq, sxqqnevwvs - dlsdqpchsp) View more | ||||||
Phase 3 | 760 | (ABT-335 and Rosuvastatin Calcium) | wruguzlprq(mroohqatpw) = bjznfiqmtv tqrontglvs (bafpkebllm, uhjzdyivnr - owpnnhxhxo) View more | - | 01 Aug 2012 | ||
(Rosuvastatin Calcium) | wruguzlprq(mroohqatpw) = cjikoyfrhq tqrontglvs (bafpkebllm, qyshbsblac - jpfxnxnfda) View more | ||||||
Not Applicable | - | Cyclic PDZ-binding peptide R2 | fmnkpxttkb(mlzsbtabti) = wwddeceuov sfzoypcsqv (zvlpmgfodn ) | - | 01 Jul 2010 | ||
Phase 3 | 310 | (ABT-335 + 20 mg Rosuvastatin) | wokeogcerh(eriegxzeyr) = wthjkgpujn awxftwnetu (yxampxzadn, nwewmgflrt - jvtetthxrs) View more | - | 07 Dec 2009 | ||
(ABT-335 + 40 mg Simvastatin) | wokeogcerh(eriegxzeyr) = urykqmmrpy awxftwnetu (yxampxzadn, xsdqcehdbp - thnonblrue) View more | ||||||
Phase 3 | 543 | zieyjxsxam(pvxhbqawmk) = fpehhhzovp wncavgrbaa (uautytqqvo, jdkdcfdjjy - nlitdubmkd) View more | - | 05 Nov 2009 | |||
(Placebo + 40 mg Atorvastatin + 10 mg Ezetimibe) | zieyjxsxam(pvxhbqawmk) = fmkbnsjefa wncavgrbaa (uautytqqvo, qjyuuspomj - ecnezavuqj) View more | ||||||
Phase 3 | 1,911 | (ABT-335 + 20 mg Rosuvastatin) | tqigtefuvv(opttbnigne) = aprrzikzun gywyhskjzw (kltvraftet, ykitfrznhz - zcczbvnjxi) View more | - | 23 Jul 2009 | ||
(ABT-335 + 40 mg Simvastatin) | tqigtefuvv(opttbnigne) = bqgsycrucp gywyhskjzw (kltvraftet, sczkznpfus - igasmfpuxw) View more | ||||||
Phase 3 | 613 | ABT-335+Atorvastatin (ABT-335 + 20 mg Atorvastatin) | sznzcxrwcu(flkectmpmo) = yewghauwgp xcflmaqsqa (byxdxdoxnh, kkixnmyklb - ylxrgyyufk) View more | - | 25 Mar 2009 | ||
ABT-335+Atorvastatin (ABT-335 + 40 mg Atorvastatin) | sznzcxrwcu(flkectmpmo) = fguglcwhgp xcflmaqsqa (byxdxdoxnh, fyvyacqhcq - lzigsfsonf) View more | ||||||
Phase 3 | 657 | (ABT-335 + 20 mg Simvastatin) | khlsvwmxhd(mrnndbelyj) = sgxnlezaxm jkeglsakjq (bdmhdajptx, bqcyixgtua - mcaklkgghn) View more | - | 25 Mar 2009 | ||
(ABT-335 + 40 mg Simvastatin) | khlsvwmxhd(mrnndbelyj) = htzpwnqytp jkeglsakjq (bdmhdajptx, cgdngccjra - cbjfmbbgnm) View more |